At nearly 59, she found success with this treatment after many failed attempts
After the initial weight loss of 13.1 kg, the placebo group regained weight, while the exercise and liraglutide groups maintained their weight loss, and the combination group lost additional weight
Growth phase Under normal cellular function, intracellular protein homeostasis is maintained by a dynamic equilibrium between protein synthesis and degradation
The dosage is gradually increased to help minimize side effects while reaching your weight loss goal
Tirzepatide How It Works Dual GIP/GLP-1 Receptor Agonist : Activates both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors, enhancing insulin secretion, reducing glucagon levels, slowing gastric emptying, and decreasing appetite